AMD linked to increased incidence of death from stroke, cardiovascular events

Article

Age-related macular degeneration (AMD) may be a useful indicator for predicting death from stroke or cardiovascular disease, according to a study published online ahead of print by the British Journal of Ophthalmology.

Age-related macular degeneration (AMD) may be a useful indicator for predicting death from stroke or cardiovascular disease, according to a study published online ahead of print by the British Journal of Ophthalmology.

Jennifer S. Tan at the University of Sydney, Australia and team assessed 3654 subjects (age ≥49 years), with follow-up at five (n=2335) and 10 (n=1952) years. Assessment included physical risk factors and medical history; causes of death were confirmed by the Australian National Death Index.

Early presentation of AMD was, after adjusting for traditional cardiovascular risk factors, linked to a twofold increase in cardiovascular mortality over a 10-year period in subjects aged <75 years at baseline. Late presentation of AMD was, after adjusting for age and gender, associated with a five times increased incidence of cardiovascular mortality and a 10 times increased incidence of stroke mortality, again in subjects aged <75 years at baseline.

The researchers concluded that this association of AMD with mortality from stroke and cardiovascular events may have implications for intravitreal anti-VEGF therapies, which are also linked with an increased risk of stroke.

Related Videos
Ramin Tadayoni, MD, speaks with Sheryl Stevenson
Jennifer I. Lim, MD, FARVO, FASRS, Director of Retina Service, University of Illinois at Chicago
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center
Carl D. Regillo, MD, FACS, FASRS, Chief of Retina Service, Wills Eye Hospital, Philadelphia, PA
Arshad Khanani, MD, MA FASRS, on a virtual call
Diana Do, MD, Professor of Ophthalmology, Byers Eye Institute, Stanford University, discusses the PHOTON study results as presented AAO
© 2024 MJH Life Sciences

All rights reserved.